Lanthanum carbonate
Lanthanum carbonate for the treatment of hyperphosphatemia in CKD 5D: multicenter, double blind, randomized, controlled trial in mainland China
11
Efficacy and safety of lanthanum carbonate on chronic kidney disease–mineral and bone disorder in dialysis patients: a systematic review
14
Conversion to lanthanum carbonate monotherapy effectively controls serum phosphorus with a reduced tablet burden: a multicenter open-label study
8
Lanthanum carbonate versus placebo for management of hyperphosphatemia in patients undergoing peritoneal dialysis: a subgroup analysis of a phase 2 randomized controlled study of dialysis patients
8
Management of hyperphosphatemia in patients with end-stage renal disease: focus on lanthanum carbonate
8
Changes in fibroblast growth factor 23 levels in normophosphatemic patients with chronic kidney disease stage 3 treated with lanthanum carbonate: results of the PREFECT study, a phase 2a, double blind, randomized, placebo-controlled trial
10
Lanthanum carbonate prevents accelerated medial calcification in uremic rats: role of osteoclast like activity
10
Lanthanum carbonate for the control of hyperphosphatemia in chronic renal failure patients: a new oral powder formulation – safety, efficacy, and patient adherence
10
Phosphorus Balance in Rats with Hypophosphatemia Induced by Lanthanum Carbonate
6
Long-term observational study in Japanese hemodialysis patients who completed a 3-year clinical study of lanthanum carbonate
10
Lanthanum carbonate is not associated with QT interval modification in hemodialysis patients
5
The management of hyperphosphatemia by lanthanum carbonate in chronic kidney disease patients
9
Comparative analysis of the phosphate-binding effects of sucroferric oxyhydroxide, ferric citrate, and lanthanum carbonate
11
Cost effectiveness of lanthanum carbonate in chronic kidney disease patients in Spain before and during dialysis
9
Effects of lanthanum carbonate versus calcium carbonate on vascular stiffness and bone mineral metabolism in hemodialysis patients with type 2 diabetes mellitus: a randomized controlled trial
8
Phosphate binders affect vitamin K concentration by undesired binding, an in vitro study
5
Effects of Calcium Carbonate, Magnesium Carbonate and Dolomite in Aluminium Alloy
9
Electrical Conductivity Of Binary Lanthanum Cuprates
6
Aragonite type lanthanum orthoborate, LaBO3
6
Foaming Agents for Powder Metallurgy Production of Aluminum Foam
6